Sign In

November 10, 2014

Researchers from MD Anderson reported at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) their attempt to estimate the cost of treating all patients in the United States with hepatitis C virus (HCV) and compare it to the potential cost savings.

November 10, 2014

The newest and most effective drugs for the treatment of hepatitis C have a cure rate of up to 98 percent, but the cost of these therapies has been controversial. Accurately assessing the cost of treating all patients with HCV in the US has yet to be determined.

November 9, 2014

Attendees of the annual meeting of the American Association for the Study of Liver Diseases (AASLD) listened to the results of a study on the adherence to its practice guidelines on testing for hepatitis B virus (HBV). Drs. Marina Serper, Kimberly Forde, and David E. Kaplan, of the University of Pennsylvania and Philadelphia VA Medical Center, examined the VA’s Corporate Data Warehouse and... More

November 9, 2014

Autoimmune hepatitis is a chronic liver disease that is found more frequently in women than men. Researchers at Indiana University studied the environmental exposures possibly related to autoimmune hepatitis and reported their findings at the annual meeting of the American Association for the Study of Liver Diseases. "Interestingly, autoimmune hepatitis is quite far behind other autoimmune... More

November 7, 2014
Janssen Therapeutics, Division of Janssen Products, LP (Janssen) has announced the U.S.
November 6, 2014
A European ICT for Health project aims to improve the quality of life of patients with chronic liver disease, by developing a remote support system to monitor their condition at home.
November 6, 2014
A new study reveals that a vaccine for hepatitis C - delivered in two doses 8 weeks apart - generated strong immune responses in volunteers, protecting them against the virus.
November 6, 2014
Researchers using coronary computed tomography angiography (CCTA) have found a close association between high-risk coronary artery plaque and a common liver disease.
November 4, 2014
The current state of hepatitis C services in England is unacceptable and a clear action plan is essential to reduce current and impending burden on the health service, save money and most...
November 3, 2014
Relapse of chronic hepatitis C virus (HVC) genotype 1 (GT-1) after initial treatment with sofosbuvir plus ribavirin therapy can be effectively re-treated with a combination of sofosbuvir plus...

Pages